Back to search

Ifosfamide in malignant mesothelioma: a phase II study

Data up to Jan 2025

Published1999
Citations18
References20

Total Citations Per Year

Abstract

References (20)

Nonparametric Estimation from Incomplete Observations

1992 • 45,923 citations

WHO Handbook for Reporting Results of Cancer Treatment

1982 • 2,214 citations

A phase II study

2000 • 757 citations

High-dose methotrexate in the treatment of malignant mesothelioma of the pleura. A phase II study

1992 • 147 citations

Paclitaxel for malignant pleural mesothelioma: a phase II study of the EORTC Lung Cancer Cooperative Group

1996 • 83 citations

Dihydro-5-azacytidine in malignant mesothelioma

1997 • 78 citations

Chemotherapy in malignant mesothelioma: a review

1991 • 70 citations

Dihydro-5-azacytidine and cisplatin in the treatment of malignant mesothelioma: a phase II study by the Cancer and Leukemia Group B.

1998 • 66 citations

Mesothelioma and Radical Multimodality Therapy: Who Benefits?

1995 • 53 citations

A phase II evaluation of ifosfamide and mesna in unresectable diffuse malignant mesothelioma: A southwest oncology group study

1992 • 42 citations

A phase II trial of dose-escalated doxorubicin and ifosfamide/mesna in patients with malignant mesothelioma

1994 • 41 citations

Combined cisplatin, doxorubicin, and mitomycin for the treatment of advanced pleural mesothelioma

1997 • 38 citations

Phase II Trial of Topotecan for the Treatment of Mesothelioma

1998 • 33 citations

An extended phase II trial of ifosfamide plus mesna in malignant mesothelioma

1992 • 33 citations

Current Therapy for Mesothelioma

1997 • 32 citations

Statistical contributions to phase II trials in cancer: interpretation, analysis and design.

1981 • 31 citations

Diagnosis and prognosis in malignant pleural mesothelioma: a prospective study.

1984 • 31 citations

Results obtained with fractionated ifosfamide massive-dose treatment in generalized malignant tumours.

1976 • 29 citations

Combined Epirubicin and Interleukin-2 Regimen in the Treatment of Malignant Mesothelioma: A Multicenter Phase II Study of the Italian Group on Rare Tumors

1998 • 20 citations

Two dose levels of ifosfamide in malignant mesothelioma

1996 • 19 citations

Cited By (0)

Loading...
Ifosfamide in malignant mesothelioma: a phase II study (1999) – Lung Cancer | Metascience Observatory Explorer